So-Young International (SY) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
6 Aug, 2026Executive summary
Achieved rapid expansion in branded aesthetic centers, reaching 49 centers by year-end 2025, the largest network nationwide by center count.
Verified treatment visits in Q4 exceeded 125,000, up 178% year-over-year, with active users surpassing 171,000.
25 centers achieved profitability and 39 generated positive operating cash flow in Q4.
Net loss attributable was RMB 108.8 million in Q4 2025, improved from RMB 607.6 million in Q4 2024; non-GAAP net loss was RMB 93.4 million.
Aesthetic treatment services became the main growth engine, with Q4 revenues up 205.3% year-over-year.
Financial highlights
Q4 2025 revenues reached RMB 460.7 million, up 24.8% year-over-year, driven by branded center expansion.
Revenues from aesthetic treatment services were RMB 248.1 million, up 205.3% year-over-year, surpassing 50% of total revenue for the first time.
Cash and equivalents at year-end 2025 were RMB 936.4 million, down from RMB 1,253.2 million a year earlier, mainly due to investment in new centers.
Basic and diluted loss per ADS improved to 1.08 from 5.92 year-over-year.
Q4 2025 gross profit was RMB 204.8 million, with gross margin at approximately 44.4%.
Outlook and guidance
2026 will focus on balancing scale and efficiency, with at least 35 new centers planned.
Q1 2026 aesthetic treatment services revenue expected between RMB 268–278 million, representing 171.2%–181.3% year-over-year growth.
Emphasis on improving profitability and gross margins as mature centers increase in proportion.
Management plans steady store expansion, operational excellence, and strategic alliances to drive sustainable value.
Latest events from So-Young International
- Revenue up 45.6% year-over-year, led by aesthetic center growth and new product launches.SY
Q1 2026 - Aesthetic treatment revenues jumped 305% YoY, but higher costs led to a net loss.SY
Q3 2025 - Aesthetic treatment services revenue soared 426% YoY, now the largest segment, with 50 centers targeted by year-end.SY
Q2 2025 - Q3 revenue exceeded guidance, with strong clinic and medical product growth and higher profitability.SY
Q3 2024 - Q2 revenue beat guidance, profit surged, but Q3 revenue is forecast to decline year over year.SY
Q2 2024 - Goodwill impairment drove a net loss, but aesthetic center revenue grew over 700% year-over-year.SY
Q4 2024 - Branded centers drove a 551% surge in treatment services revenue amid overall revenue decline.SY
Q1 2025